B

BrainChild Bio

CAR T therapies targeting CNS tumors

Cell Therapy Patient Operations Specialist

Clinical Research OperationsConfirmed live in the last 24 hours
ContractRemote in USANo salary listed

About the Job

Requirements

  • One to two years of experience in the biotech or cell therapy industry.
  • Proven experience in scheduling, planning, and logistics coordination.
  • A solid understanding of Good Manufacturing Practice (GMP) and Good Tissue Practice (GTP) requirements.
  • Ability to build and maintain cross-functional and external relationships.
  • Ability to work afternoon hours in Pacific Standard Time (PST).

Responsibilities

  • Coordinate with clinical site study coordinators, apheresis centers, contract development and manufacturing organizations (CDMOs), couriers, and internal stakeholders to maintain patient treatment schedules within established logistical and operational requirements.
  • Execute day-to-day scheduling and cell logistics activities, coordinating patient treatment milestones from enrollment through drug product delivery.
  • Support communication of scheduling updates, manufacturing milestones, product availability, and logistics requirements to clinical sites and internal stakeholders.
  • Monitor patient scheduling and logistics activities and identify, communicate, and escalate scheduling conflicts, manufacturing delays, logistics risks, chain of identity concerns, or clinical site support needs to the Director of Patient Operations in a timely manner.
  • Maintain accurate scheduling and logistics records and trackers in accordance with established Patient Operations procedures.
  • Participate in an on-call rotation and occasionally work outside standard business hours to support time-sensitive patient and product activities, as required.

Desired Qualifications

  • Experience supporting autologous cell therapy clinical trials, working with chain of identity and chain of custody processes, coordinating temperature-controlled shipments, and using scheduling or case management systems.

About the Company

BrainChild Bio

CAR T therapies targeting CNS tumors

What BrainChild Bio does: It develops CAR T cell therapies to treat tumors in the central nervous system, focusing on children first and then expanding to adults with glioblastoma. How its product works: The lead therapy, BCB-276, uses a patient’s own T cells engineered to target B7-H3, and is given directly into the cerebrospinal fluid to reach brain and spine tumors. The company is also advancing a triple-targeting candidate, BCB-214, toward initial glioblastoma testing. How it differs from competitors: BrainChild Bio relies on autologous CAR T cells delivered locoregionally into CSF, with technology licensed from Seattle Children’s and strong ties to that institution, aiming at pediatric DIPG and other CNS cancers. What its goal is: To complete the Phase 2 ILLUMINATE trial to support a future regulatory filing for BCB-276 and to broaden its pipeline for CNS tumors, including early work on glioblastoma, supported by a recent $116 million Series A.

Company size
51-200
Company stage
Series A
Total funding
$116M
Headquarters
Seattle, WA
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at BrainChild Bio

See more jobs